[Diabetic retinopathy].
D045930:Anabolic Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D002199:Capillary Permeability; D050260:Carbohydrate Metabolism; D003930:Diabetic Retinopathy / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology / Q000517:prevention & control / Q000601:surgery; D005688:Galactosamine / Q000097:blood; D012739:Gonadal Steroid Hormones / Q000627:therapeutic use; D006801:Humans; D008028:Light Coagulation; D050356:Lipid Metabolism; D012171:Retinal Vessels / Q000503:physiopathology; D013835:Thiamine Pyrophosphate / Q000627:therapeutic use; D014690:Venous Pressure; D014815:Vitamins / Q000627:therapeutic use
D045930:Anabolic Agents; D000925:Anticoagulants; D012739:Gonadal Steroid Hormones; D014815:Vitamins; D005688:Galactosamine; D013835:Thiamine Pyrophosphate
Diabeticheskaia retinopatiia